✦ LIBER ✦

Safety and efficacy of long-term velaglucerase alfa therapy in treatment-naïve adults with type 1 Gaucher disease: results from Phase III trials

✍ Scribed by Giraldo, Pilar; Zimran, Ari; Mehta, Atul; Hughes, Derralynn; Hangartner, Thomas N.; Wang, Nan; Cohn, Gabriel M.; Crombez, Eric; Elstein, Deborah

Book ID: 122207968
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 265 KB
Volume: 111
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2013.12.097

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7-year safety and efficacy with velagluc

7-year safety and efficacy with velaglucerase alfa for treatment-naïve adult patients with type 1 Gaucher disease

✍ Elstein, Deborah; Crombez, Eric; Zahrieh, David; Wang, Nan; Zimran, Ari 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 209 KB

Safety and efficacy of long-term enzyme

Safety and efficacy of long-term enzyme replacement therapy with velaglucerase alfa in patients with type 1 Gaucher disease transitioned from imiglucerase

✍ Elstein, Deborah; Giraldo, Pilar; Mehta, Atul; Pastores, Gregory; Rhead, William 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 367 KB

Safety and Efficacy of Velaglucerase Alf

Safety and Efficacy of Velaglucerase Alfa in Patients with Type 1 Gaucher Disease: 2 Years of Treatment in Phase III Trials and an Extension Study

✍ Ari Zimran; Madhulika Kabra; Pilar Giraldo; Marie-Françoise Ben Dridi; Deborah E 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Two-Year Efficacy And Safety Of Velagluc

Two-Year Efficacy And Safety Of Velaglucerase Alfa In Patients With Type 1 Gaucher Disease Switching From Imiglucerase: Phase III Trial HGT-GCB-039 And Extension

✍ Eric Crombez; Priya Kishnani; Hadhami Ben Turkia; Derlis Gonzalez; Ari Zimran; M 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 67 KB

Long-term safety and efficacy data of ta

Long-term safety and efficacy data of taliglucerase alfa, a Plant cell-expressed recombinant glucocerebrosidase, in the treatment of naïve Gaucher disease patients: 36-Month Results

✍ Zimran, Ari; Mehta, Atul; Giraldo, Pilar; Rosenbaum, Hanna; Giona, Fiorina; Amat 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

A 7-year open-label study of clinical pa

A 7-year open-label study of clinical parameters and therapeutic goals in patients with type 1 Gaucher disease receiving treatment with velaglucerase alfa: Updating the long-term experience with velaglucerase alfa

✍ Elstein, Deborah; Cohn, Gabriel; Zahrieh, David; Crombez, Eric; Zimran, Ari 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB